We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.1B
AUM Growth
–
Cap. Flow
+$20.8B
Cap. Flow
% of AUM
98.76%
Top 10 Holdings %
Top 10 Hldgs %
26.91%
Holding
1,431
New
1,431
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.1B |
| 2 |
Apple
AAPL
|
+$895M |
| 3 |
Microsoft
MSFT
|
+$781M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$593M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$523M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.88% |
| 2 | Financials | 10.47% |
| 3 | Healthcare | 9.59% |
| 4 | Consumer Discretionary | 7.62% |
| 5 | Industrials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMA
1001
DELISTED
Comerica
CMA
| $430K | ﹤0.01% |
+4,944
| New | +$398K |
|
1002
Takeda Pharmaceutical
TAK
$56.7B
| $430K | ﹤0.01% |
+27,565
| New | +$394K |
|
1003
First Hawaiian
FHB
$3.41B
| $428K | ﹤0.01% |
+16,901
| New | +$420K |
|
|
OLPX
1004
DELISTED
Olaplex Holdings
OLPX
| $427K | ﹤0.01% |
+318,418
| New | +$379K |
|
1005
HDFC Bank
HDB
$123B
| $426K | ﹤0.01% |
+11,667
| New | +$420K |
|
1006
Markel Group
MKL
$25.2B
| $426K | ﹤0.01% |
+198
| New | +$401K |
|
1007
The Bancorp
TBBK
$2.81B
| $423K | ﹤0.01% |
+6,272
| New | +$433K |
|
1008
Lennox International
LII
$15B
| $423K | ﹤0.01% |
+872
| New | +$437K |
|
1009
iShares US Aerospace & Defense ETF
ITA
$14B
| $419K | ﹤0.01% |
+1,950
| New | +$408K |
|
1010
Norwegian Cruise Line
NCLH
$9.53B
| $419K | ﹤0.01% |
+18,752
| New | +$396K |
|
1011
Hamilton Lane
HLNE
$3.88B
| $416K | ﹤0.01% |
+3,096
| New | +$389K |
|
1012
Invesco
IVZ
$12.4B
| $415K | ﹤0.01% |
+15,807
| New | +$386K |
|
1013
Prosperity Bancshares
PB
$8.9B
| $412K | ﹤0.01% |
+5,967
| New | +$403K |
|
1014
Toro Company
TTC
$8.79B
| $410K | ﹤0.01% |
+5,214
| New | +$385K |
|
1015
Kadant
KAI
$3.58B
| $408K | ﹤0.01% |
+1,432
| New | +$407K |
|
1016
Leidos
LDOS
$14.4B
| $406K | ﹤0.01% |
+2,248
| New | +$426K |
|
1017
iShares Russell Top 200 Value ETF
IWX
$3.92B
| $404K | ﹤0.01% |
+4,399
| New | +$395K |
|
1018
Nutrien
NTR
$33.9B
| $403K | ﹤0.01% |
+6,529
| New | +$384K |
|
1019
Madrigal Pharmaceuticals
MDGL
$12.6B
| $402K | ﹤0.01% |
+691
| New | +$353K |
|
1020
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.75B
| $402K | ﹤0.01% |
+6,473
| New | +$389K |
|
1021
Ryder
R
$9.9B
| $402K | ﹤0.01% |
+2,098
| New | +$377K |
|
1022
Lumentum
LITE
$46.9B
| $401K | ﹤0.01% |
+1,088
| New | +$279K |
|
1023
KB Home
KBH
$3.5B
| $401K | ﹤0.01% |
+7,107
| New | +$437K |
|
1024
US Foods
USFD
$22.5B
| $398K | ﹤0.01% |
+5,289
| New | +$397K |
|
1025
Baxter International
BAX
$12.8B
| $398K | ﹤0.01% |
+20,811
| New | +$416K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Glenmede Trust, which disclosed 1,431 positions worth $21.1B. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 1,772,161 shares worth $1.11B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Healthcare.
- Glenmede Trust's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,772,161 shares worth $1.11B.
- Glenmede Trust's ten largest holdings make up 27% of its $21.1B portfolio in Q4 2025.
- Glenmede Trust disclosed 1,431 positions in Q4 2025, its first 13F filing on record.
Based on Glenmede Trust's 13F filing for Q4 2025, filed 17 Feb 2026.